FDA-PDS Symposium III: Intermediate Endpoints in Immuno-Oncology

FDA-PDS Symposium III: Intermediate Endpoints in Immuno-Oncology Keynote The Role of Data Sharing in Fulfilling FDA’s Vision of an Evidence Generation System Robert M. Califf, MD, Commissioner, FDA Main sessions Project Data Sphere Initiative Update: Outcomes Since Symposium II [...]

FDA-PDS Symposium VI: Small Cell Lung Cancer (SCLC) External Control Arm

Symposium VI: Small Cell Lung Cancer (SCLC) External Control Arm: A Paradigm Shift in Cancer Drug Evaluation/Registration Executive Summary Keynotes Patient-Centered Datasharing:  An Imperative for Agile Innovation Paul Howard, PhD, Senior Advisor to the Commissioner, FDA NCI Clinical Data [...]

FDA-PDS Symposium IX: Rare Tumor Registries

Executive Summary PDS Symposium IX on rare cancer registries was a virtual meeting held on Oct. 7, 2020. For the first time in our annual symposia series, we are met online. As a result, more of you were able to engage which will help [...]

irAE Virtual Webinar

Teilo hosted the irAE symposium to share the progress and discuss future directions for the irAE field. Introduction and Opening Remarks Introduced to Project Data Sphere (PDS) and the event’s program; Presented overview of the landscape around ICIs and [...]

FDA-PDS Symposium X: Data Sharing

Executive Summary Overview: For the last 6 years, the CEO Roundtable on Cancer’s Project Data Sphere (PDS) has actively partnered with the FDA through a series of symposia focused on building consensus within the scientific community in support of advanced [...]

2021 Annual Meeting and Conference

ACCELERATE HEALTH was the focus of the CEO Roundtable on Cancer’s Annual Conference on November 17, 2021. Reflecting the theme, the event was broadcast from the Ingram Collection of memorable Porsche sportscars with our host, Founding CEO Roundtable on Cancer […]

2022 Annual Meeting

After two years of virtual events, the 2022 CEO Roundtable on Cancer Annual Meeting and Conference was held Nov. 1-2 on the campus of SAS Institute in Cary, NC. CEOs and other leaders gathered to discuss the state of cancer research, policy and advocacy, recruitment and retention, benefits, and wellness.

Go to Top